» Articles » PMID: 23532885

Classifying MMR Variants: Time for Revised Nomenclature in Lynch Syndrome

Overview
Journal Clin Cancer Res
Specialty Oncology
Date 2013 Mar 28
PMID 23532885
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Inactivating germline mutations in DNA mismatch repair (MMR) genes are diagnostic for Lynch syndrome. However, the clinical significance of missense variants is uncertain. A threshold level of compromised MLH1 expression, correlating with greater protein instability and MMR functional defect, has been identified to help classify the pathogenicity of missense variants.

Citing Articles

Colorectal Cancer in the Adolescent and Young Adult Population.

You Y, Lee L, Deschner B, Shibata D JCO Oncol Pract. 2020; 16(1):19-27.

PMID: 32039664 PMC: 7351341. DOI: 10.1200/JOP.19.00153.


Identification of MSH2 inversion of exons 1-7 in clinical evaluation of families with suspected Lynch syndrome.

Mork M, Rodriguez A, Taggart M, Rodriguez-Bigas M, Lynch P, Bannon S Fam Cancer. 2016; 16(3):357-361.

PMID: 28004223 PMC: 5479758. DOI: 10.1007/s10689-016-9960-y.


DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics.

de Rosa N, Rodriguez-Bigas M, Chang G, Veerapong J, Borras E, Krishnan S J Clin Oncol. 2016; 34(25):3039-46.

PMID: 27432916 PMC: 5012714. DOI: 10.1200/JCO.2016.66.6826.


High Prevalence of Hereditary Cancer Syndromes in Adolescents and Young Adults With Colorectal Cancer.

Mork M, You Y, Ying J, Bannon S, Lynch P, Rodriguez-Bigas M J Clin Oncol. 2015; 33(31):3544-9.

PMID: 26195711 PMC: 4979241. DOI: 10.1200/JCO.2015.61.4503.

References
1.
Hinrichsen I, Brieger A, Trojan J, Zeuzem S, Nilbert M, Plotz G . Expression defect size among unclassified MLH1 variants determines pathogenicity in Lynch syndrome diagnosis. Clin Cancer Res. 2013; 19(9):2432-41. DOI: 10.1158/1078-0432.CCR-12-3299. View

2.
Borras E, Pineda M, Brieger A, Hinrichsen I, Gomez C, Navarro M . Comprehensive functional assessment of MLH1 variants of unknown significance. Hum Mutat. 2012; 33(11):1576-88. DOI: 10.1002/humu.22142. View

3.
Plon S, Eccles D, Easton D, Foulkes W, Genuardi M, Greenblatt M . Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat. 2008; 29(11):1282-91. PMC: 3075918. DOI: 10.1002/humu.20880. View

4.
Heald B, Plesec T, Liu X, Pai R, Patil D, Moline J . Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center. J Clin Oncol. 2013; 31(10):1336-40. PMC: 4878100. DOI: 10.1200/JCO.2012.45.1674. View

5.
Syngal S, Fox E, Li C, DOvidio M, Eng C, Kolodner R . Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing. JAMA. 1999; 282(3):247-53. DOI: 10.1001/jama.282.3.247. View